MHRA to conduct market surveillance of medical devices in Europe

The Medicines and Healthcare products Regulatory Agency (MHRA) will conduct surveillance on the safety and functionality of medical devices used in households across Europe.

Free Report

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.

By GlobalData

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The effort is a part of a project termed as Joint Action on Market Surveillance of Medical Devices, launched officially by MHRA on 19 October this year.

MHRA director of medical devices John Wilkinson said: “We are pleased to be leading this important activity and look forward to working with our colleagues across the EU in delivering improvements to reinforce market surveillance.”

"We are pleased to be leading this important activity and look forward to working with our colleagues across the EU in delivering improvements to reinforce market surveillance."

The project is intended to reinforce the market surveillance system for medical devices by promoting the coordination of activities by all member states of the European Union, and ensuring adequate communications and cooperation considered important for the success and effectiveness of the market surveillance in the field of medical devices.

The Joint Action will be executed through five work packages, out of which MHRA will lead on three fields that are coordination, dissemination and evaluation, while the other two will be executed by EU member states the Netherlands and Ireland on the fields of manufacturers’ inspection and clinical process and resource development respectively.

The project will support the Consumers, Health, Agriculture and Food Executive Agency’s (Chafea) programme of community action within the field of health.